MedTrace Logo

Global Registry for Endovascular Aortic Treatment (GREAT)

NCT01658787 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4600

Last updated 2026-02-09

No results posted yet for this study

Summary

Prospective, observational Registry to obtain data on device performance and clinical outcomes.

Conditions

  • Multiple Pathologies

Interventions

DEVICE

Endovascular aortic repair

Treatment with Gore Endovascular Aortic Products.

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Principal Investigators

  • Ross Milner, MD, FACS · The University of Chicago Medicine & Biological Sciences

  • Dennis Gable, MD · Baylor Research Institute

  • Pierre Galvagni Silveira, MD, PhD · Coris Medicina Avançada

  • Steven R Dubenec, MD · Royal Prince Alfred Hospital, Sydney, Australia

  • Santi Trimarchi, MD · IRCCS Policlinico S. Donato

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States
  • Australia
  • Brazil
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01658787 on ClinicalTrials.gov